KBC Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87K Sell
1,574
-519
-25% -$28.7K ﹤0.01% 1289
2025
Q1
$101K Hold
2,093
﹤0.01% 1475
2024
Q4
$81K Buy
2,093
+737
+54% +$28.5K ﹤0.01% 1676
2024
Q3
$61K Hold
1,356
﹤0.01% 1624
2024
Q2
$47K Buy
1,356
+154
+13% +$5.34K ﹤0.01% 1655
2024
Q1
$35K Buy
+1,202
New +$35K ﹤0.01% 1720